FindTrial
Sign In

A prospective study of the effects of Ninjin'yoeito on anemia and depressive symptoms in postpartum women

A prospective study of the effects of Ninjin'yoeito on anemia and depressive symptoms in postpartum women - Effects of Ninjin'yoeito on anemia and depressive symptoms in postpartum women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000044116
Enrollment
1000
Registered
2021-05-06
Start date
2020-01-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum anemia

Interventions

Kracie Ninjin&#39
yoeito, 7.5g per day, 4weeks Ferrous fumarate, 1cap per day, 4weeks

Sponsors

Fukuda Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1)Patients with anemia(hemoglobin level<11g/dl)at 1 to 2 days postpartum. (2)Patients who have provided consent for participation.

Exclusion criteria

Exclusion criteria: (1) Patients having past history of aldosteronism, myopathy, liver dysfunction, or jaundice. (2)Patients whom investigators consider to be ineligible.

Design outcomes

Primary

MeasureTime frame
Change of hemoglobin levels, Prevalence of depressive symptoms as determined by the Edinburgh Postnatal Depression Scale(EPDS)—

Secondary

MeasureTime frame
Change of fatigue(NRS)—

Countries

Japan

Contacts

Public ContactSho-ichi Kawakami

Fukuda Hospital Department of Obstetrics and Gynecology

kawakami@fukuda-hp.or.jp096-322-2995

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026